An alternative pseudolikelihood method for multivariate random-effects meta-analysis

Statistics in Medicine

Volumn 34, Issue 3, 2015, Pages 361-380

  Chen, Yong ^a   Hong, Chuan ^a   Riley, Richard D ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Composite likelihood; Correlation; Multivariate meta analysis; Pseudolikelihood; Singular estimated covariance matrix problem

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARYLDIALKYLPHOSPHATASE 1; GOSERELIN; HOMOCYSTEINE; ARYLDIALKYLPHOSPHATASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ANALYTIC METHOD; ANALYTICAL ERROR; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER RADIOTHERAPY; DISEASE FREE SURVIVAL; ENZYME ACTIVITY; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; MATHEMATICAL ANALYSIS; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROBABILITY; PROSTATE CANCER; PSEUDO RESTRICTED MAXIMUM LIKELIHOOD METHOD; PSEUDOLIKELIHOOD METHOD; RANDOMIZATION; RILEY METHOD; SIMULATION; STATISTICAL BIAS; BLOOD; COMPUTER SIMULATION; CORONARY DISEASE; GENETICS; MALE; META ANALYSIS; PROSTATIC NEOPLASMS; STATISTICAL MODEL;

ARYLDIALKYLPHOSPHATASE; COMPUTER SIMULATION; CORONARY DISEASE; HOMOCYSTEINE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; PROSTATIC NEOPLASMS;

EID: 84920735785     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.6350     Document Type: Article

References (48)

1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7(3): 177-188.
2. VanHouwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Statistics in Medicine 2002; 21(4): 589-624.
3. Jones A, Riley R, Williamson P, Whitehead A. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. Clinical Trials 2009; 6 (1): 16-27.
4. Hand D. Evaluating diagnostic tests: the area under the roc curve and the balance of errors. Statistics in Medicine 2010; 29(14): 1502-1510.
5. Jackson D, Riley R, White I. Multivariate meta-analysis: potential and promise. Statistics in Medicine 2011; 30(20): 2481-2498.
6. Borenstein M, Hedges L, Higgins J, Rothstein H. Introductionto Meta-Analysis. Wiley Online Library: The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, United Kingdom, 2009.
7. Hartung J, Knapp G, Sinha BK Statistical Meta-Analysis with Applications, vol.738, Wiley-Interscience: Hoboken, New Jersey, USA 2011.
8. Daniels MJ, Hughes MD. Meta-analysis for the evaluation of potential surrogate markers. Statistics in Medicine 1997; 16(17): 1965-1982.
9. Berkey C, Antczak-Bouckoms A, Hoaglin D, Mosteller E, Pihlstrom B. Multiple-outcomes meta-analysis of treatments for periodontal disease. Journal of Dental Research 1995; 74(4): 1030-1039.
10. Nam I, Mengersen K, Garthwaite P. Multivariate meta-analysis. Statistics in Medicine 2003; 22(14): 2309-2333.
11. Wei Y, Higgins J. Estimating within-study covariances in multivariate meta-analysis with multiple outcomes. Statistics in Medicine 2013; 32(7): 1191-1205.
12. Riley R, Abrams K, Sutton A, Lambert P, Thompson J. Bivariate random-effects meta-analysis and the estimation of between-study correlation. BMC Medical Research Methodology 2007; 7(1): 15.
13. Riley R, Thompson J, Abrams K. An alternative model for bivariate random-effects meta-analysis when the within-study correlations are unknown. Biostatistics 2008; 9(1): 172-186.
14. Lindsay B. Composite likelihood methods. Contemporary Mathematics 1988; 80(1): 221-39.
15. Cox D, Reid N. A note on pseudolikelihood constructed from marginal densities. Biometrika 2004; 91(3): 729-737.
16. Varin C, Reid N, Firth D. An overview of composite likelihood methods. Statistica Sinica 2011; 21(1): 5-42.
17. Kent JT. Robust properties of likelihood ratio tests. Biometrika 1982; 69(1): 19-27.
18. Molenberghs G, Verbeke G. 2005 Models for Discrete Longitudinal Data. Springer: New York, NY 10013, USA, 2005.
19. Chandler R, Bate S. Inference for clustered data using the independence loglikelihood. Biometrika 2007; 94(1): 167-183.
20. Huber P 1967), The behavior of maximum likelihood estimates under nonstandard conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability, Vol. 1, University of California, Berkeley, CA, USA; 221-33.
21. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica: Journal of the Econometric Society 1980; 48:817-838.
22. White I. Multivariate random-effects meta-regression: updates to mvmeta. Stata Journal 2011; 11(2): 255-270.
23. Gasparrini A, Gasparrini MA. Package mvmeta, 2014.
24. Riley R, Abrams K, Lambert P, Sutton A, Thompson J. An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes. Statistics in Medicine 2007; 26(1): 78-97.
25. Little RJ, Rubin DB. Statistical Analysis with Missing Data, Vol.4. Wiley: New York, 1987.
26. Sohn S. Multivariate meta analysis with potentially correlated marketing study results. Naval Research Logistics (NRL) 2000; 47(6): 500-510.
27. Riley R. Multivariate meta-analysis: the effect of ignoring within-study correlation. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2009; 172(4): 789-811.
28. Baade P, Youlden D, Krnjacki L. International epidemiology of prostate cancer: geographical distribution and secular trends. Molecular Nutrition & Food Research 2009; 53(2): 171-184.
29. Sasse A, Sasse E, Carvalho A, Macedo L. Androgenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: a systematic review. BMC Cancer 2012; 12(1): 1-11.
30. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998; 17(24): 2815-2834.
31. Getz G, Reardon C. Paraoxonase, a cardioprotective enzyme: continuing issues. Current Opinion in Lipidology 2004; 15(3): 261-267.
32. Zhao Y, Ma Y, Fang Y, Liu L, Wu S, Fu D, Wang X. Association between pon1 activity and coronary heart disease risk: a meta-analysis based on 43 studies. Molecular Genetics and Metabolism 2011; 105:141-148.
33. Epstein FH, Diaz MN, Frei B, Vita JA, Keaney JF, Jr. Antioxidants and atherosclerotic heart disease. New England Journal of Medicine 1997; 337(6): 408-416.
34. Sterne JA, Egger M, Smith GD. Investigating and dealing with publication and other biases in meta-analysis. Bmj 2001; 323(7304): 101-105.
35. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. Journal of the American Statistical Association 1996; 91(434): 444-455.
36. Thompson JR, Minelli C, Abrams KR, Tobin MD, Riley RD. Meta-analysis of genetic studies using mendelian randomization-a multivariate approach. Statistics in Medicine 2005; 24(14): 2241-2254.
37. Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73(1): 13-22.
38. Lin DY. Cox regression analysis of multivariate failure time data: the marginal approach. Statistics in Medicine 1994; 13(21): 2233-2247.
39. Turner R, Omar R, Yang M, Goldstein H, Thompson S. A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine 2000; 19:3417-3432.
40. Higgins J, Whitehead A, Turner R, Omar R, Thompson S. Meta-analysis of continuous outcome data from individual patients. Statistics in Medicine 2001; 20(15): 2219-2241.
41. Piedbois P, Buyse M. Meta-analyses based on abstracted data: a step in the right direction, but only a first step. Journal of Clinical Oncology 2004; 22(19): 3839-3841.
42. Smith C, Williamson P, Marson A. Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes. Statistics in Medicine 2005; 24(9): 1307-1319.
43. Clarke M, Stewart L, Tierney J, Williamson P. Individual patient data meta-analyses compared with meta-analyses based on aggregate data. The Cochrane Library 2008).
44. Riley R, Lambert P, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. British Medical Journal 2010; 340(7745): 521-525.
45. Piedbois P, Buyse M. Meta-analysis based on individual patient data: example of advanced colorectal cancer. Recherche en Soins Infirmiers 2010; 101:25-28.
46. Di Leo A, Desmedt C, Bartlett JM, Piette F, Ejlertsen B, Pritchard KI, Larsimont D, Poole C, Isola J, Earl H, Mouridsen H, O'Malley FP, Cardoso F, Tanner M, Munro A, Twelves CJ, Sotiriou C, Shepherd L, Cameron D, Piccart MJ, Buyse M, HER2/TOP2A Meta-analysis Study Group. Her2 and top2a as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data. The Lancet Oncology 2011; 12(12): 1134-1142.
47. Rothstein H, Sutton A, Borenstein M. Publication Bias in Meta-Analysis. Wiley Online Library: The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, United Kingdom 2005.
48. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56(2): 455-463.